GSK_Annual_Report_2021

Financial Statements GlaxoSmithKline Pharmaceuticals Limited 156 CasH FLow StatEmEnt for tHE YEar EndEd MarcH 31, 2021 ` in Lakhs Year Ended March 31, 2021 Year Ended March 31, 2020 A. CASH FLOW FROM OPERATING ACTIVITIES Profit/(Loss) before income tax and exceptional items 76.22 19.60 Adjustments for : Provision for doubtful loans and advances - 42.92 Provision written back - (47.32) Interest income classified as investing cash flows (38.71) (1,45.67) Change in operating assets and liabilities (Increase) in Other non-current assets (2,77.16) (12.19) (Increase)/Decrease in Other current assets (10,00.70) 79.65 (Increase)/Decrease in Inventories (23,35.96) - Increase /(Decrease) in Trade payables 18,85.37 (3.29) (Decrease) / Increase in Other liabilities 1.28 (10.83) Cash generated from operations (16,89.66) (77.13) Income taxes paid (net of refunds) (4.34) (17.57) Cash flow before exceptional items (16,94.00) (94.70) Net cash outflow from operating activities A (16,94.00) (94.70) B. CASH FLOW FROM INVESTING ACTIVITIES (Purchase) / sale of bank deposits with maturity period more than 3 months but less than 12 months (73,00.00) - Redemption in bank deposits with maturity period more than 3 months but less than 12 months 83,00.00 500.00 Interest received 44.36 1,73.28 Net cash inflow from investing activities B 10,44.36 6,73.28 Net increase / (decrease) in cash and cash equivalents (A + B) (6,49.64) 5,78.58 Cash and cash equivalents as at 1 st April, 2020 (opening balance) 678.36 99.78 Cash and cash equivalents as at 31 st March, 2021 (closing balance) 28.72 6,78.36 Net increase / (decrease) in cash and cash equivalents (6,49.64) 5,78.58 NOTES: Cash and cash equivalents include: Balances with banks 28.72 6,78.36 Total cash and cash equivalents 28.72 6,78.36 The Cash Flow Statement has been prepared under the “Indirect Method” as set out in Indian Accounting Standard-7 on Cash Flow Statements issued by the Institute of Chartered Accountants of India. As per our report of even date attached For and on behalf of the Board For CORNELIUS & DAVAR CHARTERED ACCOUNTANTS (Firm’s Registration No.101963W) Sridhar Venkatesh Director DIN: 07263117 Puja Thakur Director DIN: 07971789 RUSTOM D. DAVAR (PARTNER) Membership No. F10620 Place : Mumbai Date: May 10, 2021 UDIN: 21010620AAAABG3059 Rohan Mota Company Secretary ACS 38473